FilingReader Intelligence
COFCO Biotechnology gets D-allulose regulatory approval
July 11, 2025 at 08:02 AM UTC•By FilingReader AI
COFCO Biotechnology has received regulatory approval from China's National Health Commission to produce and sell D-allulose, an alternative sweetener, in the domestic market.
The approval establishes the prerequisite for the company's future production and sales of the product. COFCO Biotechnology has not yet commenced production or sales of D-allulose.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
SZSE:000930•Shenzhen Stock Exchange
News Alerts
Get instant email alerts when COFCO Biotechnology publishes news
Free account required • Unsubscribe anytime